Literature DB >> 9620709

Are angiostatin and endostatin cures for cancer?

A L Harris1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9620709     DOI： 10.1016/S0140-6736(98)22022-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Efficient inhibition of growth of metastatic cancer cells after resection of primary colorectal cancer by soluble Flt-1.

Authors:  Yong Zhang; Ao Li; Weizhen Peng; Jue Sun; Fangming Xu; Jianhua Xu
Journal:  Tumour Biol       Date:  2015-04-21

Review 2.  The rationale and future potential of angiogenesis inhibitors in neoplasia.

Authors:  G Gasparini
Journal:  Drugs       Date:  1999-07       Impact factor: 9.546

3.  PEP06 polypeptide 30 exerts antitumour effect in colorectal carcinoma via inhibiting epithelial-mesenchymal transition.

Authors:  Siming Yu; Linna Li; Wei Tian; Dan Nie; Wei Mu; Fang Qiu; Yu Liu; Xinghan Liu; Xiaofeng Wang; Zhimin Du; Wen-Feng Chu; Baofeng Yang
Journal:  Br J Pharmacol       Date:  2018-06-15       Impact factor: 8.739

4.  The immunopharmacologic potential of Semaxanib and new generation directed therapeutic drugs: Receptor tyrosine kinase regulation with anti-tumorigenensis/angiogenesis properties.

Authors:  John J Haddad
Journal:  Saudi Pharm J       Date:  2011-09-23       Impact factor: 4.330

5.  Phase II trial of the antiangiogenic agent IM862 in metastatic renal cell carcinoma.

Authors:  G Deplanque; S Madhusudan; P H Jones; S Wellmann; K Christodoulos; D C Talbot; T S Ganesan; A Blann; A L Harris
Journal:  Br J Cancer       Date:  2004-11-01       Impact factor: 7.640

6.  Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer.

Authors:  K J O'Byrne; M I Koukourakis; A Giatromanolaki; G Cox; H Turley; W P Steward; K Gatter; A L Harris
Journal:  Br J Cancer       Date:  2000-04       Impact factor: 7.640

7.  Autophagy inhibition contributes to Endostar sensitization in esophageal squamous cell carcinoma.

Authors:  Xinghua Han; Zhanggui Wang; Bin Hu; Jianming Xu
Journal:  Oncol Lett       Date:  2017-09-21       Impact factor: 2.967
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.